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change physician behavior by implementing new protocols and continue to mon-
itor ongoing administrations of multiple CT scans. The study also warrants poten-
tial investigation of similar European hospital databases.
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OBJECTIVES: The economic crisis has led Greece to adopt measures towards re-
ducing public pharmaceutical expenditure. One of the most important key sectors
addressed was that of the market share of generics. The aim of the study was to
evaluate stakeholder’s perceptions of the recently introduced or planned pharma-
ceutical policy reforms regarding generics policy in Greece. METHODS: A qualita-
tive study, using the method of semi-structured interviews was conducted. We
identified 24 decision makers and opinion leaders from public and private organi-
zations, after developing an influence map. In total 17 interviews were conducted,
using an open-ended questions guide. The interviews were tape recorded, tran-
scribed and content analyzed. RESULTS: The majority of stakeholders perceived
the prices of generics as “high” and “non-competitive” and their pricing system as
problematic, also highlighting the lack of incentives for increased use of generics
that results in low penetration in the market. An important issue strongly empha-
sized was the introduction of stricter audit and quality control mechanisms. Re-
garding INN prescribing, stakeholders appeared to be skeptical for both its effec-
tiveness and its viability, as concerns focusing on the maturity of the system, on
the culture and education of the physicians and on the lack of monitoring mecha-
nisms, cannot guarantee its effective implementation. CONCLUSIONS: There is
general agreement that a generics policy in Greece should aim at having low prices
and higher generic penetration in the market, by introducing incentives for all
stakeholders as well as ensuring the quality and safety of generics. The introduc-
tion of INN was not clearly deemed as a measure that can assist to achieve the goal
of containing pharmaceutical expenditure. The pricing system of generics has now
been reformed, leading to lower prices. Further policy measures are needed in the
framework of a comprehensive generics policy in order to increase generics con-
sumption.
PHP93
DEVELOPMENT OF BIOSIMILAR MARK IN EU-5 AND USA
Ammar H1, Rémuzat C2, Houas M3, Toumi M4
1Creativ-Ceutical, Paris, France, 2Creativ-Ceutical France, Paris, France, 3Creativ-ceutical Paris,
Paris, France, 4University Claude Bernard Lyon 1, Lyon, France
OBJECTIVES: Identify differences of biosimilar uptakes across the EU big five:
France, Italy, Germany, UK, Spain, and USA. METHODS: We identified policies and
biosimilars market shares in volume and value in EU big five: France, Italy, Ger-
many, UK, Spain and USA. We browsed websites of EU and national (when appli-
cable) drug agencies, ministries of health, HTA bodies, payers, manufacturer
unions etc. We completed our research with literature search and grey reports, as
well as Datamonitor reports, IMS data and proprietary pharmavitae database.
RESULTS: Contrary to FDA, EMA has a well defined regulatory path for biosimilars.
However, when the US Patient Protection and Affordable Care Act 2010 enters into
force in 2014, the biosimilars market will be boosted. Today 80% of this market is in
EU. While uptakes in Spain and UK have started to increase, Germany and France
account currently for half of the biosimilars market by value in EU with a 36% and
19% share respectively. In UK, biosimilars have had low penetration, and in Italy
the market is far behind other countries. Other countries with apparently high
sales of biosimilars like Greece are source countries for parallel market. Obviously
there is no overlap between the generics market size and the biosimilars one. The
slow uptake versus generics can be explained by the low discount of biosimilar
price versus branded products and the uncertainty about the clinical effect.
CONCLUSIONS: The lack of regulatory path in USA makes difficult the launch of
biosimilars. However, EU is the experimental field where companies develop their
ability to capture this market. Small molecule generics continue representing the
main source of cost savings in Europe. Biosimilars represent a huge opportunity for
cost saving in the future especially in the USA where the biologic market is leader.
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OBJECTIVES: To examine predictors of drug therapy problems (DTP) among pa-
tients who received a telephonic medication therapy management (MTM)
program. METHODS: Retrospective data was collected from 712 Medicaid patients
who received an initial medication therapy review (MTR) as part of a statewide
telephonic MTM program during an 18-month period. Data was extracted from two
administrative claims files for health care utilization and prescription dispensing
information and one medical record file for MTM program information. For analy-
ses, the main outcome variable was the number of pharmacist-identified DTPs
during the initial MTR. Univariate and multivariate models examined the variables
of age, sex, co-morbid conditions, number of inpatient, outpatient, and emergency
department (ED) visits, number of total, chronic, and narrow therapeutic index
drugs, total medication doses per day, and the number of prescribers and dispens-
ing pharmacies for their relationship with the main outcome. For all medication
and service utilization variables, only data from the three months prior to the MTR
were included. RESULTS: At least one DTP was identified in 61.1% of patients (per
patient mean 22/ 25.) Univariate analyses found that female sex, diagnosis of
hyperlipidemia, number of ED visits, number of total and chronic medications,
total medication doses per day, and the number of pharmacies where patients had
prescriptions filled were significantly (p 0.05) associated with having more DTPs.
In multivariate analyses, female sex, diagnosis of hyperlipidemia, number of ED
visits, and number of total and chronic medications remained as significant pre-
dictors (p0.05) of DTPs. In sensitivity analyses for 10, 20, 30, and 40 or more DTPs
per patient, these variables remained significant predictors in the models except
for number of chronic medications. CONCLUSIONS: Providers and policymakers
planning the implementation of MTM services, particularly for Medicaid patients,
may benefit from considering these findings in defining targeted populations for
service delivery.
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OBJECTIVES: The objective of this paper was to examine the performance of 90
public general hospitals of the Greek National Health System (GNHS) in 2010, rank
hospitals according to their efficiency and identify potentials for input reductions.
Additionally, the aim of the study was to identify best practices regarding procure-
ment policies for pharmaceuticals and other medical goods used by the most effi-
cient hospitals. METHODS: Data Envelopment Analysis (DEA) was used for the
estimation of efficiency scores. The number of beds, doctors, management and
nursing personnel and total hospital expenditures were used as inputs and number
of patient admissions, patient days, outpatient visits and surgical interventions as
outputs. In order to identify best practices regarding the efficient performance of
the leading hospitals, a panel of academic experts and executives of the three top
performing hospitals, was used. RESULTS: The results show that only 31% of Greek
hospitals are efficient, with a mean efficiency score of 85.5%. Among hospitals with
the highest efficiency scores (100%) were two University hospitals and one private-
non profit hospital. All three hospitals managed on average, an 11.6% decrease in
pharmaceutical expenditure and 20.1% in the procurement of orthopaedics-pros-
thetics and other medical goods compared to the previous year. At the same time,
the number of admissions increased on average by 8.1% and the number of surgical
interventions also increased in to hospitals by more than 2%. Regarding the best
practices used, the experts agreed that among the most effective procurement
policies are tendering and renegotiation with a number of suppliers. Additionally,
they all agreed that the introduction of e-procurement decreased pharmaceutical
and other medical goods consumption. CONCLUSIONS: If the GNHS was to elimi-
nate inefficiency it could save up to 208.5 million euro or 10.3 % of the total budget
allocated to public hospitals in 2010.
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OBJECTIVES: In difficult economic periods policymakers implement cost-contai-
ment measures in the specialty care. Therefore hospital managers have to improve
the technical efficiency of operation. In Hungary merger of hospitals were initiated
to take advantage of economies of scale. Our objective was to assess whether the
merger of the Clinical Center of University of Pecs and the Hospital of Baranya
County in 2010 improved the sustainability and technical efficiency of these
institutions. METHODS: Our analysis was based on data from the controlling sys-
tem of these institutions. We compared revenues, costs, number of cases and
performance data before (2009) and after the merger (2011). RESULTS: After the
merger the National Health Insurance Fund Administration (NHIFA) cut the per-
formance volume limit (PVL) of the institution by 11,7%. This resulted in a reduc-
tion of patient volumes and revenues. The number of cases decreased differen-
tially: it fell by 9,2% on those departments that were previously operated parallel by
both institutions, and only by 2,7% on those department that were earlier only
operated by the Clinical Center. The total bed utilization rate also declined by 6,2%.
The management of the Clinical Center could reduce the operational costs by 958
million HUF by decreasing the number of staff and renegotiating supply contracts.
However due to the decreasing PVL the cost/DRG increased from 136’600 to 149’600
HUF/DRG. CONCLUSIONS: The management of the hospitals applied ceteris pari-
bus assumptions when predicting the outcomes of merge prior to the decision.
NHIFA implemented serious cost-containment measures as a consequence of the
economic crisis. Despite of significant reduction in operational costs, the technical
efficiency of the Clinical Center declined. The institution could not properly adapt
to the loss of revenue caused by the PVL reduction after the merger. In difficult
economic period the ceteris paribus assumption has to be supplemented with
scenario analysis.
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OBJECTIVES: However, the number of disabled pensioner under and in normal
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retirement age has decreased in the past few years, it is still quite high. 29,8 % (2010)
of the population receive pension, allowance and pension-like providing. More
than one fouth of them are disabled pensioners whose 50 per cent are under the
retirement age limit. This causes a considerable medical and economic problem.
METHODS:We have examined the alteration of the number of disabled pensioners
living in Hungary in regard to sex and age distribution according to the datas of
KSH. We have examined the number of the disabled pensioners in relation of total
pensioners, in relation of the underaged and in normal retirement age. RESULTS:A
total of 49.5 % of the disabled pensioners are at the normal retirement age limit.
They are altogether 7.5 % of the total population. The proportion of the underaged
disabled pensioners was 13.9 % on average. In the Central Hungary is 10 % of the
retired population, in the region of Central Transdanubian region 11 %, in the
Southern Transdanubian region 18 %, in the Northern Hungarian region 16 %, in the
Northern Great Plain region 18 %, in the Southern Great Plain it is 11 % in 2010. The
rate of the underaged disabled pensioners is in Tolna, Békés, Szabolcs and in Cson-
grád county is the highest, and int he capital and int he Western Transdanubian
counties is the lowest. The gender distribution of disabled pensioners is around 50
% in every region. CONCLUSIONS: The large number of the disabled pensioners,
especially who are under the age limit, and their proportion of the total and retired
population can be explained by labour market and health conditional reasons
which signifies serious health and economic problems.
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OBJECTIVES: It is known that based on information asymmetries there are differ-
ences in patients’ preferences and experts’ judgments. This review intends to as-
sess the available literature to display congruence and differences between patient
preferences and physician judgments in regard of methods, attributes used as well
as diseases. METHODS: Systematic literature review in PubMed/Medline was fo-
cused on the methods Conjoint-Analysis, Discrete-Choice-Experiment, Standard-
Gamble, Time-Trade-Off and Paired Comparison. Out of 836 articles found 102 met
the inclusion criteria and were transferred to abstracts/full-text-analysis. 46 stud-
ies were extracted comparing patient preferences and experts’ judgments.
RESULTS: Out of 46 studies 13 used Conjoint-Analyses, 10 Discrete-Choice-Exper-
iments, 4 Paired-Comparisons, 8 Time-Trade- /Probability-Trade-Offs, 10 Stan-
dard-Gamble and 4 Controlled-Preference-Scales and Prospective-Measures. 8 out
of 10 Discrete-Choice-Experiments resulted in a high degree of commonality, while
9 out of 13 Conjoint-Analyses resulted in a certain rate of disagreement. Overall, 23
studies showed poor concordance between preferences and judgments, 11 studies
resulted in a reasonable agreement. Thus, studies can be defined with three differ-
ent distinctions: - no meaningful /significant difference of preferences and judg-
ments verifiable, - no significant difference in the ranking, but meaningful differ-
ences of strengths, - meaningful /significant differences. CONCLUSIONS: Despite
evidence that patients and health care providers often do not agree on treatment
decisions, the magnitude and direction of these differences varies depending on
the condition or the procedure of interest. The review showed that there was
higher concordance between patients and health care providers when the condi-
tion was chronic or the service was preventative. However, it cannot be concluded
that one certain elicitation-method always resulted in a disagreement while an-
other technique always resulted in agreement. The studies indicated that for most
conditions physicians underestimated the impact of side or treatment effects on
patients’ quality of life. Differences in perceptions may be due, in part, to ineffec-
tive communication between the provider and the patient.
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OBJECTIVES: Emergency Department (ED) overcrowding (OC) is plaguing EDs
worldwide with grave implications on patient and caregiver comfort and quality of
care. Many contributing factors have been cited and many approaches tried, with-
out widespread success. Focused Operations Management (FM) integrates novel
managerial theories and practical tools {such as the Theory of Constraints (TOC),
the Pareto principle, the complete kit concept and the Just-in-Time/LEAN ap-
proach} into a systematic approach. It has proved effective in the industry and
service sectors, radically improving performance at little additional cost. This ap-
proach has great potential but has not been previously adopted in EDs . As a first
research phase, interviews with key stakeholders were performed to identify op-
erational causes and potential operational remedies. METHODS: Major ED opera-
tional challenges, metrics and alleviating measures were extracted through a lit-
erature search. Semi-structured interviews with ED head nurses ED managers,
hospital administrators and Ministry of Health administrators were conducted.
The interviews centered on validation of major challenges identified in the litera-
ture, charting unreported challenges and assessing potential utility of FM tools.
RESULTS: The major challenges identified included ED boarding, prolonged length
of stay, unjustified ED utilization and slow access to specialist consults, lab tests
and imaging studies. The FM tools assessed to be most promising were ”the com-
plete kit” concept and TOC methods to identify and alleviate bottle necks and to
reduce “work in progress”. Major differences were found in the ranking of five
major ED operational challenges between hospital administrators and ED direc-
tors. While ED directors and head nurses ranked as first: ED overcrowding due to
patient boarding, it was not ranked at all among the five major challenges by
hospital administrators. CONCLUSIONS: Improving ED operations is a critical
health management issue. An important initial step towards charting possible
alleviating measures, is mapping of the challenges and root causes and agreeing on
a common language among stakeholders.
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OBJECTIVES:To assess preferences for Health Technology Assessment (HTA) fund-
ing criteria of a large sample of Australians broadly reflecting the population of
Queensland, Australia. METHODS: Adults (n930) were recruited via an internet
panel managed by a market research company. Participation quotas broadly re-
flected the Queensland population by gender and age. Participants completed a
Discrete Choice Experiment (DCE) as part of a wider survey on HTA decision crite-
ria. Attributes/levels were based on criteria used in Queensland and a literature
review. An orthogonal design (72 choice sets) was used, with participants random-
ized to one block of 6 sets. Choice data were analysed using a multinomial logit
model. RESULTS: Participants strongly preferred a technology offering prevention
or early diagnosis, and less strongly preferred one that improves quality of life,
reduces side effects, or reduces hospital waiting times, compared to technologies
improving survival by one year. Participants also strongly preferred treating 35yr
old recipients, followed by 10yr olds and then 60yr olds, rather than 85yr olds.
Technologies that assist Queenslanders living in rural areas, those providing value
for money, those with no available alternative, and technologies assisting indige-
nous Australians were also prioritised over their counterparts. However, all these
advantages were considered relatively less important than achieving prevention or
early diagnosis, which equated to approximately double the other gains when
marginal rates of substitution were calculated using number benefiting as the
denominator. CONCLUSIONS: If consistency with public preferences is a require-
ment for “fair” HTA decision-making criteria, this study provides broad support for
criteria used to assess technologies in Queensland. The findings send a clear mes-
sage of the importance of prevention and early diagnosis as compared to treatment
of existing disease from the public’s perspective.
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OBJECTIVES: In Greece Diagnostic Related Groups (DRGs) were implemented in
October 2011. Still their implementation is challenged by social security funds due
to its high cost vs. previous per capita reimbursement system. The objective of the
study was to investigate the actual cost of two DRG’s in Greece emerging from three
major hospitals.METHODS:A multicenter bottom up cost component analysis was
conducted using 69 patients’ files from three hospitals to estimate the direct cost
per patient. The mean cost per patient and the length of stay (LOS) were calculated
for heart failure and for infection/inflammation of the respiratory system. The
analysis was carried out with regard to: i) biopathological exams ii) diagnostics, and
iii) pharmaceuticals. Econometric analysis was explored to estimate the impact of
each cost component on total cost per patient. The results were compared with the
official reimbursement prices of the Ministry of Health. The discrepancies between
the estimated cost and the official prices of DRG’s were assessed using the coeffi-
cient of variation (CoV). RESULTS: The average cost for heart failure (DRG K42X)
was 657.81€ and its official price was 849 €. The CoV were the following: 59% for
biopathological exams, 155% for diagnostic exams, 117% for Pharmaceuticals, and
57% for the average cost per patient. The CoV for the average LOS was 47%. For the
DRG of infection of respiratory system the estimated average cost per patient was
1122.89 € and the official price was 1040 €. The estimated discrepancies per cost
component were: 106% for biopathological exams, 136% for diagnostic exams,
165% for Pharmaceuticals, and 134% for the overall average cost per patient. For the
average length of stay the CoV was 77% CONCLUSIONS: The launching of DRG
system in Greece presents it own unique challenges but further research is needed
to verify the DRG mechanism and focus on more DRG’s costing.
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OBJECTIVES: The mission of the health system is providing health of the society
and satisfaction is an aspect of the human health. Measurement of patients’ sat-
isfaction is a way for evaluating health system services. The purpose of this study
was to measure patients’ satisfaction with pharmacy physical space, services and
staff behavior. METHODS: A total of 797 pharmacy customers randomly selected
from 22 districts of Tehran -the capital city of Iran- completed an anonymous,
self-administered questionnaire. RESULTS: Including 3.5 as moderate level of sat-
isfaction, there was some dissatisfaction (mean3.5, pvalue0.05) about the allo-
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